Combined diet and exercise reduces intrapancreatic fat more than either alone

Across all studies, lifestyle modification produced a significant reduction in IPFD: a standardized mean difference of −0.26 (95% CI −0.36 to −0.16, p<0.0001) with low statistical heterogeneity (I²=12.9%), translating to an absolute reduction of approximately 1.02% of pancreatic fat (95% CI −1.30 to −0.73). Subgroup analysis revealed that combined diet-and-exercise interventions achieved the largest numerical reduction (SMD −0.41), followed by exercise alone (SMD −0.26) and diet alone (SMD −0.22), though these differences were not statistically significant (p=0.40). The study found no evidence of publication bias, strengthening confidence in the overall finding. A major limitation is that study sample sizes and intervention durations were not formally reported, making it difficult to judge clinical meaningfulness or optimal program length. The analysis suggests structured lifestyle programs targeting both diet and physical activity may offer a non-pharmacological pathway to reduce pancreatic fat accumulation.

The meta-analysis included studies ranging across different populations and intervention durations, with MRI-based fat quantification as the gold standard. The combined-intervention effect size (SMD −0.41) was numerically larger than single-modality approaches, but the confidence intervals overlapped substantially, meaning the true difference could be smaller or even absent in some populations. Proposed mechanisms suggest that exercise improves insulin sensitivity and promotes fat oxidation, while dietary caloric restriction and carbohydrate reduction directly lower hepatic and pancreatic lipid stores. Interestingly, the pancreas appears more responsive to lifestyle change than some other ectopic fat depots, though absolute fat loss per intervention was small (roughly 1% in MRI units). The study notes that heterogeneity in outcome measurement, intervention intensity, and baseline metabolic health across the 23 trials means some subgroups—such as people with existing pancreatic dysfunction or severe obesity—may respond differently than the pooled average suggests. No long-term data on whether sustained IPFD reduction translates to fewer pancreatic disease events were available in the included studies.